These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2736229)

  • 1. The occurrence of interval cancers in the Nijmegen screening programme.
    Peeters PH; Verbeek AL; Hendriks JH; Holland R; Mravunac M; Vooijs GP
    Br J Cancer; 1989 Jun; 59(6):929-32. PubMed ID: 2736229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The current detectability of breast cancer in a mammographic screening program. A review of the previous mammograms of interval and screen-detected cancers.
    van Dijck JA; Verbeek AL; Hendriks JH; Holland R
    Cancer; 1993 Sep; 72(6):1933-8. PubMed ID: 8364871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival in interval breast cancer in the DOM screening programme.
    Brekelmans CT; Peeters PH; Deurenberg JJ; Collette HJ
    Eur J Cancer; 1995 Oct; 31A(11):1830-5. PubMed ID: 8541108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interval breast cancer characteristics before, during and after the transition from screen-film to full-field digital screening mammography.
    van Bommel RMG; Weber R; Voogd AC; Nederend J; Louwman MWJ; Venderink D; Strobbe LJA; Rutten MJC; Plaisier ML; Lohle PN; Hooijen MJH; Tjan-Heijnen VCG; Duijm LEM
    BMC Cancer; 2017 May; 17(1):315. PubMed ID: 28476109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The detectability of breast cancer by screening mammography.
    Ciatto S; Rosselli Del Turco M; Zappa M
    Br J Cancer; 1995 Feb; 71(2):337-9. PubMed ID: 7841050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term breast cancer screening in Nijmegen, The Netherlands: the nine rounds from 1975-92.
    Otten JD; van Dijck JA; Peer PG; Straatman H; Verbeek AL; Mravunac M; Hendriks JH; Holland R
    J Epidemiol Community Health; 1996 Jun; 50(3):353-8. PubMed ID: 8935470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Missed and true interval and screen-detected breast cancers in a population based screening program.
    Hoff SR; Samset JH; Abrahamsen AL; Vigeland E; Klepp O; Hofvind S
    Acad Radiol; 2011 Apr; 18(4):454-60. PubMed ID: 21216632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of mammographic breast density on breast cancer screening performance: a study in Nijmegen, The Netherlands.
    van Gils CH; Otten JD; Verbeek AL; Hendriks JH; Holland R
    J Epidemiol Community Health; 1998 Apr; 52(4):267-71. PubMed ID: 9616416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. So-called interval cancers of the breast. Pathologic and radiologic analysis of sixty-four cases.
    Holland R; Mravunac M; Hendriks JH; Bekker BV
    Cancer; 1982 Jun; 49(12):2527-33. PubMed ID: 7074569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of interval breast cancers diagnosed among participants of the Nova Scotia Breast Screening Program.
    Payne JI; Caines JS; Gallant J; Foley TJ
    Radiology; 2013 Jan; 266(1):96-103. PubMed ID: 23169791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of overdiagnosis of breast cancer in screening with mammography: results of the Nijmegen programme.
    Peeters PH; Verbeek AL; Straatman H; Holland R; Hendriks JH; Mravunac M; Rothengatter C; Van Dijk-Milatz A; Werre JM
    Int J Epidemiol; 1989 Jun; 18(2):295-9. PubMed ID: 2788627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The visibility of cancer on earlier mammograms in a population-based screening programme.
    Saarenmaa I; Salminen T; Geiger U; Holli K; Isola J; Kärkkäinen A; Pakkanen J; Piironen A; Salo A; Hakama M
    Eur J Cancer; 1999 Jul; 35(7):1118-22. PubMed ID: 10533457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for breast cancer in Nijmegen. Report of 6 screening rounds, 1975-1986.
    Peeters PH; Verbeek AL; Hendriks JH; van Bon MJ
    Int J Cancer; 1989 Feb; 43(2):226-30. PubMed ID: 2917799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammographic parenchymal patterns and mode of detection: implications for the breast screening programme.
    Sala E; Warren R; McCann J; Duffy S; Day N; Luben R
    J Med Screen; 1998; 5(4):207-12. PubMed ID: 9934652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth rate of invasive ductal carcinomas from a screened 50-74-year-old population.
    Otten JD; van Schoor G; Peer PG; den Heeten GJ; Holland R; Broeders MJ; Verbeek AL
    J Med Screen; 2018 Mar; 25(1):40-46. PubMed ID: 28084888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interval breast cancers: absolute and proportional incidence and blinded review in a community mammographic screening program.
    Carbonaro LA; Azzarone A; Paskeh BB; Brambilla G; Brunelli S; Calori A; Caumo F; Malerba P; Menicagli L; Sconfienza LM; Vadalà G; Brambilla G; Fantini L; Ciatto S; Sardanelli F
    Eur J Radiol; 2014 Feb; 83(2):e84-91. PubMed ID: 24369953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour characteristics of bilateral screen-detected cancers and bilateral interval cancers in women participating at biennial screening mammography.
    van Bommel R; Lameijer JRC; Voogd AC; Nederend J; Louwman MWJ; Setz-Pels W; Strobbe LJ; Tjan-Heijnen VCG; Duijm LE
    Eur J Radiol; 2018 Nov; 108():215-221. PubMed ID: 30396659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammography screening in the county of Fyn. November 1993-December 1999.
    Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
    APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.